RA Capital Management’s RxSight RXST Stock Holding History

RA Capital Management’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,702,967	Closed	-$48.1M	–	71
2025 Q2	$48.1M	Sell	3,702,967 -40,051	-1%	-$602K	0.81%	27
2025 Q1	$94.5M	Hold	3,743,018	–	–	1.58%	18
2024 Q4	$129M	Sell	3,743,018 -173,807	-4%	-$7.84M	1.71%	14
2024 Q3	$194M	Buy	3,916,825 +222,000	+6%	+$11.4M	2.23%	12
2024 Q2	$222M	Buy	3,694,825 +252,000	+7%	+$14.4M	2.94%	8
2024 Q1	$178M	Buy	3,442,825 +38,540	+1%	+$1.89M	2.26%	9
2023 Q4	$137M	Buy	3,404,285 +351,489	+12%	+$10.3M	2.14%	10
2023 Q3	$85.1M	Hold	3,052,796	–	–	1.68%	18
2023 Q2	$87.9M	Hold	3,052,796	–	–	1.66%	18
2023 Q1	$50.9M	Hold	3,052,796	–	–	1.15%	29
2022 Q4	$38.7M	Hold	3,052,796	–	–	0.78%	36
2022 Q3	$36.6M	Hold	3,052,796	–	–	0.78%	39
2022 Q2	$43M	Hold	3,052,796	–	–	1.15%	29
2022 Q1	$37.8M	Hold	3,052,796	–	–	0.82%	39
2021 Q4	$34.3M	Hold	3,052,796	–	–	0.61%	48
2021 Q3	$38.7M	Buy	+3,052,796	New	+$42M	0.54%	47

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RA Capital Management's RXST Position: Q3 2025 in Review

RA Capital Management sold out of RxSight (RXST) in Q3 2025, closing a stake of 3,702,967 shares — an estimated $48.1M sold.

RA Capital Management first reported a position in RXST in Q3 2021 and held it in 16 quarters. The position peaked at $222M in Q2 2024. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

RA Capital Management reported no remaining RxSight position as of Q3 2025 after selling out during the quarter.
RA Capital Management sold 3,702,967 RxSight shares in Q3 2025, an estimated $48.1M.
RA Capital Management first reported a position in RxSight in Q3 2021 and held it in 16 quarters.
RA Capital Management's RxSight position peaked at $222M in Q2 2024.
160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on RA Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.